The document describes smart cytology screening technologies that automate the analysis of gynecological and non-gynecological cytology samples, processing thousands of cells within minutes and presenting abnormal cells for review. The system supports remote screening and is HIPAA-compliant, with an emphasis on utilizing machine learning to enhance image analysis. It is labeled by FDA regulations for research use only and is designed for efficient setup, validation, and training with known diagnosis slides.